Novel AI blood test detects liver cancer

A novel AI blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center.

Study: First-degree relatives of patients with NAFLD are at risk of liver disease

Approximately one-fourth of the general population worldwide has nonalcoholic fatty liver disease, known as NAFLD,.

Fatty liver is increasingly the cause of liver cell cancer

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. In Germany, there are.

Diets rich in refined fiber may increase liver cancer risk in some individuals

Many people commonly consume fiber-enriched foods to promote weight loss and prevent chronic diseases such.

US residents of Mexican descent may have a higher risk of liver cancer with each successive generation

The risk of hepatocellular carcinoma (HCC) in individuals of Mexican descent living in Los Angeles.

Deep in the bile duct, researchers explore how cancer arises

A Wilmot Cancer Institute scientist discovered how gene mutations fuel the growth of bile duct.

B vitamins can potentially be used to treat advanced non-alcoholic fatty liver disease

Scientists at Duke-NUS Medical School in Singapore have uncovered a mechanism that leads to an.

A roadmap for the future of hepatitis B therapy development

Worldwide, 880,000 people die each year as a result of infection with the hepatitis B.

Shrinking liver cancer tumors before transplant yields excellent outcomes, researchers report

Treating liver cancer tumors to shrink them in order to allow the patient to qualify.

Researchers develop blood test to predict liver cancer risk

An estimated one-quarter of adults in the U.S. have nonalcoholic fatty liver disease (NAFLD), an.